Changes of bone turnover markers during perioperative anthracycline- and/or taxane-based chemotherapy in pre- and postmenopausal patients with primary breast cancer

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Rauschenbach, N. [1 ]
Kurbacher, A. T. [1 ]
Sperling, S. [1 ]
Herz, S. [1 ]
Monreal, K. [1 ]
Kurbacher, J. A. [1 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Bonn, Nrw, Germany
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P4-10-17
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-10-17
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Su Jin Lee
    Yoon La Choi
    Yeon Hee Park
    Seung Tae Kim
    Eun Yoon Cho
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 743 - 751
  • [42] OOTR-N006: mTOR inhibition with everolimus in invasive breast cancer patients after pre-operative use of anthracycline and/or taxane-based chemotherapy.
    Chow, Louis W. C.
    Im, Seock-Ah
    Ng, Ting Ying
    Lee, Min Hyuk
    Lim, Cheol Wan
    Kim, Sung Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] First Efficacy Results of Capecitabine with Anthracycline- and Taxane-Based Adjuvant Therapy in High-Risk Early Breast Cancer: A Meta-Analysis
    Jiang, Yiwei
    Yin, Wenjin
    Zhou, Liheng
    Yan, Tingting
    Zhou, Qiong
    Du, Yueyao
    Shen, Zhenzhou
    Shao, Zhimin
    Lu, Jinsong
    PLOS ONE, 2012, 7 (03):
  • [44] Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Lee, Su Jin
    Choi, Yoon La
    Park, Yeon Hee
    Kim, Seung Tae
    Cho, Eun Yoon
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 743 - 751
  • [45] Bone turnover markers in postmenopausal breast cancer patients treated with fulvestrant.
    Agrawal, A.
    Hannon, R. A.
    Cheung, K. L.
    Eastell, R.
    Robertson, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 47S - 47S
  • [46] β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer
    Youqun Xiang
    Yinlong Yang
    Guilong Guo
    Xiaoqu Hu
    Huxiang Zhang
    Xiaohua Zhang
    Yifei Pan
    Clinical and Experimental Medicine, 2016, 16 : 391 - 397
  • [47] Quantitative Research: Changes in Neurofilament Light, a Marker of Axonal Damage in Breast Cancer Patients Receiving Taxane-Based Chemotherapy
    Simonelli, Mary
    Zulewski, David
    NURSING RESEARCH, 2020, 69 (03) : E162 - E163
  • [48] Impact of adjuvant anthracycline-based and taxane-based chemotherapy on plasma VEGF levels and cognitive function in early-stage breast cancer patients
    Ng, R.
    Phey, X. Y.
    Ng, T.
    Yeo, H. L.
    Shwe, M.
    Gan, Y. X.
    Ho, H. K.
    Chan, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] β3-tubulin is a good predictor of sensitivity to taxane-based neoadjuvant chemotherapy in primary breast cancer
    Xiang, Youqun
    Yang, Yinlong
    Guo, Guilong
    Hu, Xiaoqu
    Zhang, Huxiang
    Zhang, Xiaohua
    Pan, Yifei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (03) : 391 - 397
  • [50] Changes in biochemical markers of bone turnover in breast cancer patients with bone metastases
    Vrbanec, D
    Belev, B
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S10 - S10
12345